Cargando…

Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome

OBJECTIVES: Type I IFN (IFN-I) activation is a prominent feature of primary SS (pSS), SLE and SSc. Ultrasensitive single-molecule array (Simoa) technology has facilitated the measurement of subfemtomolar concentrations of IFNs. Here we aimed to measure IFN-α2 in serum from pSS, SLE and SSc using a S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huijser, Erika, Göpfert, Jens, Brkic, Zana, van Helden-Meeuwsen, Cornelia G, Jansen, Sanne, Mandl, Thomas, Olsson, Peter, Schrijver, Benjamin, Schreurs, Marco W J, van Daele, Paul L A, Dik, Willem A, Versnel, Marjan A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071525/ https://www.ncbi.nlm.nih.gov/pubmed/34505866 http://dx.doi.org/10.1093/rheumatology/keab688

Ejemplares similares

Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome
por: Huijser, Erika, et al.
Publicado: (2022)

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
por: Maria, Naomi I, et al.
Publicado: (2014)

Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype
por: Huijser, Erika, et al.
Publicado: (2022)

Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
por: Wahadat, M Javad, et al.
Publicado: (2022)

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
por: Brkic, Zana, et al.
Publicado: (2013)

Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics
por: Kolijn, P. Martijn, et al.
Publicado: (2023)

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)

Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
por: Huijser, Erika, et al.
Publicado: (2021)

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets
por: Bodewes, Iris L. A., et al.
Publicado: (2019)

Distal renal tubular acidosis in primary Sjögren syndrome
por: Both, Tim, et al.
Publicado: (2012)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply
por: Brkic, Zana, et al.
Publicado: (2014)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis: implications for diagnosis
por: Schrijver, Benjamin, et al.
Publicado: (2020)

Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland
por: Wildenberg, Manon E, et al.
Publicado: (2008)

The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man
por: Maria, Naomi I, et al.
Publicado: (2015)

Blood myxovirus resistance protein‐1 measurement in the diagnostic work‐up of suspected COVID‐19 infection in the emergency department
por: Tong‐Minh, Kirby, et al.
Publicado: (2022)

The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis
por: Welzen-Coppens, Jojanneke M. C., et al.
Publicado: (2013)

The Gene Expression Profile of CD11c(+)CD8α(−) Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse
por: Beumer, Wouter, et al.
Publicado: (2014)

Autoantibodies in Sjögren's syndrome and its classification criteria
por: Veenbergen, Sharon, et al.
Publicado: (2021)

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
por: Hamkour, Safae, et al.
Publicado: (2023)

Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis
por: Both, Tim, et al.
Publicado: (2016)

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
por: Flessa, Christina-Maria, et al.
Publicado: (2022)

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
por: Wahadat, M. Javad, et al.
Publicado: (2018)

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
por: Collins, Alexis, et al.
Publicado: (2021)

Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2
por: Hermans, Maud A. W., et al.
Publicado: (2021)

Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes
por: Imgenberg-Kreuz, Juliana, et al.
Publicado: (2016)

Digital image analysis of intraepithelial B-lymphocytes to assess lymphoepithelial lesions in salivary glands of Sjögren’s syndrome patients
por: van Ginkel, Martha S, et al.
Publicado: (2022)

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2021)

Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study
por: Wahadat, Mohamed Javad, et al.
Publicado: (2023)

Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
por: Both, Tim, et al.
Publicado: (2017)

Interferons in Sjögren’s Syndrome: Genes, Mechanisms, and Effects
por: Li, He, et al.
Publicado: (2013)

Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?
por: La Distia Nora, Rina, et al.
Publicado: (2018)

Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients
por: van der Houwen, Tim B, et al.
Publicado: (2020)

Interferons and Dry Eye in Sjögren’s Syndrome
por: Ogawa, Yoko, et al.
Publicado: (2018)

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
por: Ducreux, Julie, et al.
Publicado: (2016)

Dysregulated miRNome of plasmacytoid dendritic cells from patients with Sjögren’s syndrome is associated with processes at the centre of their function
por: Hillen, Maarten R, et al.
Publicado: (2019)

Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity
por: Mandl, Thomas, et al.
Publicado: (2017)

Cigarette smoking and the risk of primary Sjögren’s syndrome: a nested case control study
por: Olsson, Peter, et al.
Publicado: (2017)

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Burska, Agata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t93ea80vuhhkmo9ql5aj86hgfa